(Q42164079)

17 October 2017

title

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study (English)

1 reference

17 October 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Walter Pirker

1

1 reference

17 October 2017

Schiva Djamshidian

2

1 reference

17 October 2017

Susanne Asenbaum

3

1 reference

17 October 2017

Willibald Gerschlager

4

1 reference

17 October 2017

Gotthard Tribl

5

1 reference

17 October 2017

Martha Hoffmann

6

1 reference

17 October 2017

Thomas Brücke

7

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

17 October 2017

1 reference

17 October 2017

volume

17

1 reference

17 October 2017

issue

1

1 reference

17 October 2017

page(s)

45-53

1 reference

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

17 October 2017

cites work

1 reference

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

21 January 2018

1 reference

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

21 January 2018

1 reference

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

21 January 2018

1 reference

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

21 January 2018

1 reference

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

21 January 2018

1 reference

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.

21 January 2018

1 reference

Clinicopathologic observations in essential tremor: report of six cases.

21 January 2018

1 reference

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

21 January 2018

1 reference

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

21 January 2018

1 reference

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

Progression of Parkinson's disease without levodopa

21 January 2018

1 reference

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

21 January 2018

1 reference

Clinical observations on the rate of progression of idiopathic parkinsonism

21 January 2018

1 reference

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

Survival of patients with pathologically proven multiple system atrophy: a meta-analysis

21 January 2018

1 reference

Progressive supranuclear palsy: a survey of the disease course.

21 January 2018

1 reference

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

21 January 2018

1 reference

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

21 January 2018

1 reference

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

21 January 2018

1 reference

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.1265

1 reference

17 October 2017

1 reference